Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression

P C Belitsos1, J E Hildreth, J T August

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Insights

Monoclonal antibody H4C4 induces homotypic aggregation of hemopoietic cells by targeting the CD44 (Pgp-1) glycoprotein. This cell adhesion process involves the cytoskeleton and is temperature-sensitive.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Monoclonal antibodies (mAbs) are crucial tools in cell biology research.
  • Homotypic aggregation is a key process in cellular interactions and tissue formation.
  • The CD44 (Pgp-1) molecule's role in cell adhesion is under investigation.

Purpose of the Study:

  • To investigate the function of a novel monoclonal antibody (mAb H4C4) in inducing cell aggregation.
  • To identify the antigen recognized by mAb H4C4 and elucidate its role in hemopoietic cell interactions.
  • To explore the molecular mechanisms underlying CD44-mediated cell aggregation.

Main Methods:

  • Development and characterization of a monoclonal antibody (mAb H4C4).
  • In vitro induction of homotypic aggregation in hemopoietic cells and cell lines.
  • Protein purification, immunologic cross-reactivity, and tryptic fragment sequencing to identify the target antigen.
  • Functional assays using inhibitors (cytochalasin B, sodium azide, etc.) and varying temperatures.

Main Results:

  • mAb H4C4 induced in vitro homotypic aggregation of various hemopoietic cells.
  • The antigen recognized by mAb H4C4 is an 85-kDa glycoprotein identified as CD44 (equivalent to murine Pgp-1).
  • Cell aggregation was temperature-sensitive, inhibited by cytochalasin B, suggesting cytoskeletal involvement, and unaffected by other tested agents.
  • An inverse relationship between spontaneous aggregation and cell-surface CD44 expression was observed.

Conclusions:

  • CD44 (Pgp-1) plays a fundamental role in hemopoietic cell aggregation.
  • The aggregation process mediated by CD44 involves the cellular cytoskeleton.
  • mAb H4C4 is a valuable reagent for studying CD44-mediated cell adhesion.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...